Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
DPP4 inhibitors have a very minimal effect on endogenous incretins (GLP-1, GIP) Dual GLP-1/GIP agonists (Tirzepatide) possess the properties of both incretins and are associated with more significant weight loss than GLP-1 agonist monotherapy
If eligible, we'll provide the prescription treatment options you need to accomplish your goals
ZhaoLXiongZLuXZhengSWangFGeLet al
We can help no matter if youre in the hospital or at home
For the oGTT, body weights were recorded and at the start of the experiment mice were given 2 g kg 1 of glucose (100 mg ml - 1 ) by oral gavage, and blood glucose was monitored at 0, 15, 30, 60, 90, and 120 min using an Accu-Chek Guide glucometer from tail blood